Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The process of managing medications in patients with borderline personality disorder.

Silk KR.

J Psychiatr Pract. 2011 Sep;17(5):311-9. doi: 10.1097/01.pra.0000405361.88257.4a.

PMID:
21926526
2.

Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic.

Sansone RA, Rytwinski D, Gaither GA.

Compr Psychiatry. 2003 Nov-Dec;44(6):454-8.

PMID:
14610722
3.

Medication utilization patterns and methods of suicidality in borderline personality disorder.

Makela EH, Moeller KE, Fullen JE, Gunel E.

Ann Pharmacother. 2006 Jan;40(1):49-52. Epub 2005 Nov 22.

PMID:
16303987
4.

Psychopharmacologic management of patients with borderline personality disorder.

Links PS, Steiner M.

Can J Psychiatry. 1988 Jun;33(5):355-9. Review.

PMID:
3044565
5.

The Use of Psychotropic Drug Therapy in Borderline Personality Disorder: a Case Report.

Bradford R, Holt C.

Psychiatr Danub. 2015 Sep;27 Suppl 1:S371-4.

6.

Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.

Kutcher SP, Blackwood DH.

Can J Psychiatry. 1989 May;34(4):347-53. Review.

PMID:
2567621
7.

Transference and the vicissitudes of medication use by borderline patients.

Waldinger RJ, Frank AF.

Psychiatry. 1989 Nov;52(4):416-27. Review.

PMID:
2685859
8.

'I think we're all guinea pigs really': a qualitative study of medication and borderline personality disorder.

Rogers B, Acton T.

J Psychiatr Ment Health Nurs. 2012 May;19(4):341-7. doi: 10.1111/j.1365-2850.2011.01800.x. Epub 2011 Sep 28.

PMID:
22070628
9.

Management and effectiveness of psychopharmacology in emotionally unstable and borderline personality disorder.

Silk KR.

J Clin Psychiatry. 2015 Apr;76(4):e524-5. doi: 10.4088/JCP.14com09534.

10.

Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, Kasper S, Greil W.

Eur Neuropsychopharmacol. 2015 Jun;25(6):763-72. doi: 10.1016/j.euroneuro.2015.03.017. Epub 2015 Apr 11.

PMID:
25907249
11.

Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.

Kolla NJ, Eisenberg H, Links PS.

Arch Suicide Res. 2008;12(1):1-19. doi: 10.1080/13811110701542010. Review.

PMID:
18240030
12.

Clinicians' experiences in combining medication and psychotherapy in the treatment of borderline patients.

Waldinger RJ, Frank AF.

Hosp Community Psychiatry. 1989 Jul;40(7):712-8.

PMID:
2777227
13.

Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.

Amad A, Thomas P, Perez-Rodriguez MM.

Curr Pharm Des. 2015;21(23):3311-6. Review.

PMID:
26088114
14.

Pharmacotherapy of borderline outpatients.

Zanarini MC, Frankenburg FR, Gunderson JG.

Compr Psychiatry. 1988 Jul-Aug;29(4):372-8.

PMID:
3409692
15.

Borderline personality disorder.

Magill MK, Garrett RW.

Am Fam Physician. 1987 Jan;35(1):187-95.

PMID:
3799420
16.

Borderline personality disorder: nursing interventions using dialectical behavioral therapy.

Osborne UL, McComish JF.

J Psychosoc Nurs Ment Health Serv. 2006 Jun;44(6):40-7. Review.

PMID:
16789592
17.

Fluoxetine trial in borderline personality disorder.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

Psychopharmacol Bull. 1990;26(1):151-4.

PMID:
2371370
18.

The Core Conflictual Relationship Themes (CCRT) in borderline personality disorder.

Drapeau M, Perry JC.

J Pers Disord. 2009 Aug;23(4):425-31. doi: 10.1521/pedi.2009.23.4.425.

PMID:
19663662
19.

Comparison of attachment styles in borderline personality disorder and obsessive-compulsive personality disorder.

Aaronson CJ, Bender DS, Skodol AE, Gunderson JG.

Psychiatr Q. 2006 Spring;77(1):69-80.

PMID:
16397756
20.

Quality of life in borderline personality disorder.

IsHak WW, Elbau I, Ismail A, Delaloye S, Ha K, Bolotaulo NI, Nashawati R, Cassmassi B, Wang C.

Harv Rev Psychiatry. 2013 May-Jun;21(3):138-50. doi: 10.1097/HRP.0b013e3182937116. Review.

PMID:
23660969

Supplemental Content

Support Center